Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-25-003095
Filing Date
2025-11-14
Accepted
2025-11-14 16:06:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 21305
  Complete submission text file 0000921895-25-003095.txt   23214
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Subject) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90376 | Film No.: 251485883
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)